Scott J Weir

This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: University of Kansas, Stowers Institute for Medical Research, The Childrens' Mercy Hospital. Active years: 2013-2025.

USPTO Granted Patents = 4 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 1

Location History:

Lawrence, KS (US) (2013 - 2016)
Olathe, KS (US) (2017)

Company Filing History:

Stowers Institute for Medical Research

patents

1 out of 25

The Childrens' Mercy Hospital

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12186332 - Methods for overcoming WNT/beta-catenin anti-cancer resistance in leukemia stem cells (2025-01-07),

2. 9545413 - Methods of forming ciclopirox or derivatives thereof in a subject by administration of prodrug (2017-01-17),

3. 9243014 - Method of treatment with prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin in-2-1H-one and derivatives thereof (2016-01-26),

4. 8609637 - Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1H)-one and derivatives thereof (2013-12-17),

Title: Scott J Weir: Innovator in Cancer Treatment

Introduction

Scott J Weir is a notable inventor based in Lawrence, KS (US), recognized for his contributions to cancer treatment through innovative methods. He holds a total of 4 patents, showcasing his commitment to advancing medical science and improving patient outcomes.

Latest Patents

Weir's latest patents include groundbreaking methods for overcoming WNT/beta-catenin anti-cancer resistance in leukemia stem cells. This patent provides methods for treating cancers, including leukemia, using low doses of anthracyclines such as doxorubicin. Another significant patent involves methods of forming ciclopirox or its derivatives in a subject through the administration of a prodrug. This method can treat various conditions, including fungal infections and multiple types of leukemia, by effectively converting a prodrug compound into an active therapeutic agent within the body.

Career Highlights

Throughout his career, Scott J Weir has worked with esteemed institutions such as the University of Kansas Medical Center Research Institute and the Stowers Institute for Medical Research. His work in these organizations has significantly contributed to the field of medical research, particularly in oncology.

Collaborations

Weir has collaborated with notable colleagues, including Mehmet Tanol and Linheng Li, enhancing the scope and impact of his research through teamwork and shared expertise.

Conclusion

Scott J Weir's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His patents reflect a dedication to finding effective solutions for complex health challenges.